Pediatrics Research and Adolescent Medicine

About Conference

The 11th International Conference on Pediatrics Research and Adolescent Medicine, scheduled for October 06-07, 2025, in the dazzling city of Las Vegas, USA, is a premier gathering for researchers, healthcare professionals, academicians, and industry leaders dedicated to advancing pediatric and adolescent healthcare. This global event will provide an unparalleled platform for knowledge exchange, collaboration, and innovation. Attendees will engage in sessions covering a wide range of topics, including neonatal care, adolescent mental health, advancements in pediatric diseases, innovative treatments, and strategies to promote holistic well-being in children and adolescents. With keynote sessions, panel discussions, and interactive workshops led by globally renowned experts, participants will gain valuable insights into the latest trends, research, and treatments, improving clinical skills and patient outcomes.

Attending the Pediatrics Research Conference plays a crucial role in the ongoing education of healthcare professionals, including physicians, nurses, and technicians. It offers a unique opportunity for professionals to stay up-to-date on emerging challenges and advancements in pediatric and adolescent medicine, while also contributing to the future development of new treatments. Moreover, the conference allows attendees to network with renowned experts, exchange ideas, and collaborate on innovative solutions. Set against the backdrop of Las Vegas, famously known as the “Entertainment Capital of the World,” the event provides not only a world-class academic experience but also the chance to explore the city’s vibrant culture, iconic landmarks, and world-class dining.

Why to Attend?

The 11th International Conference on Pediatrics Research and Adolescent Medicine, taking place on October 6-7, 2025, in Las Vegas, USA, is a premier platform for professionals dedicated to pediatric and adolescent healthcare. This conference offers a unique opportunity to:

• Gain Insights into the latest advancements in pediatrics and adolescent medicine
• Engage with leading experts in child health, neonatology, and developmental medicine
• Present your research through poster presentations
• Earn CPD credits to enhance professional growth
• Participate in hands-on workshops and interactive discussions
• Network with global researchers, clinicians, and industry leaders
• Foster collaborations for future research and clinical advancements
• Discover emerging trends shaping the future of pediatric healthcare

Target Audience:

Pediatricians
Pediatric Nutritionists
General Physicians
Neonatologist
Pediatric Associates
Pharmacists
Pediatric Nurses
Scientists
Pediatric Faculty       
Medical Colleges
Data Management Companies
Training Institutes
Software developing companies
Business Entrepreneurs
Associations and Societies
Pharmaceutical companies
Media partners

Sessions & Tracks

Track 01: Advances in Neonatal Care

Advances in neonatal care have revolutionized the outcomes for premature and critically ill infants, significantly improving both survival rates and long-term health. Innovations such as the use of high-frequency oscillatory ventilation and non-invasive ventilation for respiratory support have been pivotal in helping premature infants with underdeveloped lungs breathe more easily. These technologies allow for more precise management of oxygen delivery and CO2 removal. Neonatal care has also made significant strides in monitoring, with innovations in neonate-specific pulse oximeters, thermoregulation systems, and advanced phototherapy devices for jaundice management. The integration of family-centered care models, which encourage the involvement of parents in the infant's care, has fostered better emotional well-being for both parents and babies, contributing to faster recovery. The role of neonatal intensive care units in improving survival rates is further enhanced by continuous research into the impact of prematurity on long-term developmental outcomes. Researchers are also investigating the potential of stem cell therapies and regenerative medicine to repair damaged tissues and improve outcomes for infants with severe conditions.

Track 02: Pediatric Nutrition and Obesity Management

Pediatric nutrition plays a crucial role in child development, with recent advancements focusing on combating childhood obesity, which has reached epidemic levels in many countries. Research has shown that early intervention is critical, and there is now a stronger emphasis on personalized nutrition. Tailored nutritional plans, considering genetics, metabolic profiles, and activity levels, help ensure that children receive balanced diets that promote optimal growth and health. Advances in gut microbiome research have also shown that a balanced microbiome plays a key role in managing weight, making probiotic and prebiotic interventions a promising avenue for managing obesity. Pediatric obesity management programs now include multidisciplinary approaches, involving dietitians, psychologists, and physical therapists. Behavioral therapy is a crucial element, with cognitive-behavioral approaches being increasingly used to help children and families understand and address the underlying psychological factors contributing to obesity. The rise of digital health tools, including apps, wearables, and telehealth consultations, has further empowered families by providing real-time feedback on children’s diet and exercise patterns, making interventions more proactive and personalized.

Track 03: Adolescent Mental Health

Adolescent mental health has emerged as a critical area of focus due to increasing rates of anxiety, depression, and other mental health challenges. Research into the biological and environmental factors affecting adolescent mental health has led to a better understanding of how genetics, hormonal changes, and environmental stressors contribute to conditions like depression, anxiety, and eating disorders. Advances in treatments have expanded beyond traditional therapy and medication, with personalized approaches that consider the individual’s biological, psychological, and social contexts. Cognitive-behavioral therapy has proven effective in addressing anxiety and depression, and new pharmacological treatments, such as selective serotonin reuptake inhibitors, are providing better management options. The increasing accessibility of mental health services via telemedicine and online therapy platforms has made it easier for adolescents to access care. Schools are becoming critical partners in mental health care, providing early intervention programs and peer-led initiatives that help reduce the stigma surrounding mental illness. Research into social media’s impact on adolescent mental health has led to the development of strategies to combat cyberbullying and social media-related stress.

Track 04: Infectious Diseases in Pediatrics

Infectious diseases remain one of the leading causes of morbidity and mortality among children worldwide, despite significant progress in vaccines and hygiene practices. Emerging diseases along with traditional illnesses like influenza, pneumonia, and gastrointestinal infections, continue to affect pediatric populations, especially in resource-limited settings. Advances in molecular diagnostics and rapid testing technologies have enhanced the ability to identify pathogens quickly, enabling more targeted treatments and reducing unnecessary use of antibiotics. The development of new vaccines, including those for human papillomavirus, rotavirus, and recent RSV vaccines, has significantly reduced the incidence of certain infectious diseases. Challenges persist, particularly in underserved areas where vaccine hesitancy, lack of access, and misinformation contribute to lower vaccination rates. Additionally, the rise of antibiotic-resistant bacteria is a growing concern, as it complicates the treatment of infections in children. Pediatric infectious disease specialists are working on novel therapies, vaccines, and diagnostic tools, as well as promoting antimicrobial stewardship to combat the rise of resistant pathogens.

Track 05: Chronic Diseases in Childhood

The prevalence of chronic diseases in children, including asthma, type 1 and type 2 diabetes, and obesity, has risen dramatically in recent years. Asthma, one of the most common chronic conditions, has seen significant improvements in management, with better medication delivery devices such as breath-actuated inhalers and biologic therapies targeting specific inflammatory pathways. Advances in continuous glucose monitoring systems and insulin pumps have revolutionized the management of pediatric diabetes, allowing for more stable blood glucose control and fewer complications. Research into diabetes vaccines and gene therapies holds promise for more effective long-term treatments. Childhood obesity remains a global challenge, with increasing recognition of its link to future cardiovascular diseases, metabolic syndrome, and sleep apnea. Pediatricians now emphasize early intervention, promoting healthy eating habits, physical activity, and behavioral interventions as part of a comprehensive treatment strategy. Addressing the root causes of childhood obesity involves a multi-faceted approach, including better school nutrition policies, community programs, and improved access to healthcare services for families.

Track 06: Pediatric Surgery Innovations

Pediatric surgery has seen tremendous advancements, particularly with the advent of minimally invasive techniques. Laparoscopic surgery, for instance, has greatly reduced the size of incisions, leading to faster recovery times, less post-operative pain, and reduced infection risk for children. For conditions such as appendicitis, hernias, and certain congenital malformations, minimally invasive surgery has become the standard. Robotics has taken this further, allowing for even greater precision in complex procedures, such as those involving the heart, brain, or spinal cord. Additionally, advances in imaging technology, including 3D ultrasound, MRI, and real-time intraoperative navigation, have improved pre-surgical planning and allowed for more precise execution during surgery. These innovations have not only improved the outcomes of pediatric surgeries but also reduced the ph ysical and psychological stress on young patients. Enhanced post-operative care protocols, including pain management and rehabilitation, have further contributed to quicker recovery times and better long-term health outcomes.

Track 07: Global Child Health

Global child health continues to face significant challenges, particularly in low- and middle-income countries, where millions of children suffer from preventable diseases, malnutrition, and lack of access to adequate healthcare. Malnutrition remains a leading cause of childhood morbidity and mortality, particularly in sub-Saharan Africa and parts of Asia. Efforts to improve maternal and child nutrition, along with vaccines for diseases like pneumonia and diarrheal diseases, have led to significant reductions in child mortality worldwide. However, challenges like antibiotic resistance, emerging infectious diseases, and mental health issues remain a global concern. Global health organizations and governments are collaborating to enhance healthcare infrastructure, improve immunization rates, and ensure equitable access to medical treatments. The integration of telemedicine, mobile health solutions, and community-based healthcare models is helping to bridge the gap in rural and underserved areas, ensuring that more children have access to life-saving treatments and services.

Track 08: Genetic Disorders in Pediatrics

Genetic disorders in pediatrics encompass a broad range of conditions, from rare genetic syndromes to more common inherited conditions such as cystic fibrosis, sickle cell disease, and hemophilia. Advances in genetic testing, including whole-genome sequencing, have revolutionized the diagnosis of these conditions, enabling earlier detection and more accurate prognostication. The ability to identify genetic mutations associated with diseases like Duchenne muscular dystrophy and fragile X syndrome has opened up new avenues for targeted therapies. Gene therapy is emerging as a promising treatment for certain genetic conditions, with ongoing clinical trials investigating its effectiveness. Newborn screening programs have expanded globally, allowing for the early detection, facilitating earlier intervention and improving long-term outcomes. The field of precision medicine is also advancing, with treatment plans becoming increasingly tailored to a child’s genetic makeup, offering hope for more effective treatments and, potentially, cures for previously untreatable conditions.

Track 09: Developmental and Behavioral Pediatrics

Developmental and behavioral pediatrics is an area of healthcare focused on diagnosing and managing conditions related to developmental delays, learning disabilities, and behavioral disorders. Autism spectrum disorder, attention-deficit/hyperactivity disorder, and learning disabilities are increasingly recognized and diagnosed earlier, thanks to advancements in screening and diagnostic tools. Neuroimaging, genetic testing, and behavioral assessments have enhanced diagnostic accuracy, allowing for more individualized treatment plans. Applied behavior analysis, cognitive-behavioral therapy , and pharmacological treatments are commonly used to address issues associated with ASD and ADHD, providing children with the tools they need to thrive. Developmental and Behavioral Pediatrics rises of early intervention programs, which focus on providing support to children in their formative years, has been shown to significantly improve developmental outcomes. The collaboration between pediatricians, psychologists, occupational therapists, and speech therapists ensures a multidisciplinary approach to addressing complex developmental and behavioral needs. Research into the genetic and environmental factors contributing to these conditions continues to improve our understanding, with the potential for new therapies and interventions on the horizon.

Track 10: Pediatric Emergency Medicine

Pediatric emergency medicine continues to evolve, with specialized care now available for the acute management of trauma, infections, respiratory distress, and other emergencies in children. One significant advance is the development of pediatric-specific protocols for trauma care, including tailored resuscitation techniques and medications for children in crisis situations. Telemedicine has greatly improved access to pediatric emergency care, especially for families in remote or underserved areas. Emergency medicine specialists are now able to consult with pediatricians in real-time for guidance on complex cases, such as rare illnesses or difficult-to-diagnose symptoms. Advances in diagnostic imaging, such as point-of-care ultrasound, have allowed for faster diagnoses, particularly in cases of abdominal trauma, cardiac distress, and respiratory conditions. Furthermore, the development of pediatric trauma centers and more effective pain management strategies have significantly improved outcomes for children experiencing emergencies.

Track 11: Adolescent Reproductive Health

Adolescent reproductive health is a critical area of focus, addressing the physical, emotional, and social needs of adolescents as they transition through puberty. There has been increasing awareness around issues such as sexual education, contraception access, and preventing sexually transmitted infections. Effective programs that promote comprehensive sexual education and access to reproductive healthcare services have shown to improve outcomes for adolescents, including reducing teen pregnancy rates and preventing STIs. The introduction of long-acting reversible contraceptives and HPV vaccines has been instrumental in promoting reproductive health. Additionally, discussions on mental health and reproductive rights have gained attention, highlighting the importance of providing adolescents with a supportive environment that respects their autonomy while ensuring they have the knowledge and resources to make informed decisions about their reproductive health. These efforts are crucial in reducing disparities in healthcare access and empowering young people to navigate their reproductive journey with confidence and safety.

Track 12: Innovations in Pediatric Oncology

Pediatric oncology has seen tremendous progress with the development of novel therapies that improve survival rates for children diagnosed with cancer. Immunotherapy, including chimeric antigen receptor T-cell therapy, has revolutionized the treatment of certain pediatric cancers, particularly blood cancers like leukemia and lymphoma. This treatment harnesses the child’s own immune system to target and eliminate cancer cells more effectively. Precision medicine, driven by genetic profiling of tumors, allows for more personalized treatments, minimizing side effects and improving outcomes. Development of less invasive surgeries and advanced radiotherapy techniques has reduced complications and enhanced recovery. Clinical trials continue to be essential in testing new drugs, furthering advancements in pediatric oncology and offering hope for more effective, less toxic cancer treatments for children. These efforts are paving the way for a future where more cancers can be cured with treatments that cause fewer long-term side effects.

Track 13: Pediatric Cardiology Advance

Recent advances in pediatric cardiology have transformed the diagnosis and treatment of congenital and acquired heart conditions in children. Innovations in imaging techniques, such as 3D echocardiography and cardiac MRI, have provided more detailed insights into heart function, aiding in earlier and more accurate diagnoses. The advent of catheter-based interventions has reduced the need for open-heart surgery in many cases, making procedures safer and less invasive. For congenital heart defects, advances in surgical techniques and post-operative care have significantly improved long-term survival rates. Advancements in heart failure management, including the use of ventricular assist devices and heart transplants, have further enhanced the care of children with severe heart conditions. Personalized medicine, including genetic testing, is increasingly being used to guide treatment plans and improve patient outcomes, offering new hope for the future of pediatric cardiology.

Track 14: Telemedicine in Pediatrics

Telemedicine has revolutionized pediatric care by enabling remote consultations, improving access to healthcare, and reducing barriers to care for families in rural or underserved areas. Pediatric telemedicine allows for the monitoring of chronic conditions, follow-up consultations, and behavioral health support through virtual visits. The convenience and accessibility of telehealth have been especially beneficial in managing conditions such as asthma, diabetes, and developmental disorders, where continuous monitoring is crucial. Telemedicine became an essential tool for maintaining healthcare access while minimizing exposure to infectious diseases. Ongoing developments in telemedicine platforms and wearable health technology promise to further enhance pediatric care, offering real-time health data, facilitating remote diagnostics, and expanding the reach of healthcare professionals. These innovations have made healthcare more convenient, flexible, and inclusive, helping to bridge gaps in access and provide care to populations that previously faced challenges in reaching healthcare services.

Track 15: Ethical Issues in Pediatric Medicine

Ethical issues in pediatric medicine are complex, as they often involve decisions made by parents, caregivers, and healthcare providers on behalf of minors. Consent, autonomy, and the best interests of the child are central to many ethical dilemmas in pediatric care. One of the most pressing concerns arises in life-threatening situations, where decisions about the initiation or withdrawal of treatment must balance quality of life, long-term outcomes, and family wishes. In these cases, the question of whether to pursue aggressive treatment or opt for palliative care can be deeply challenging. Pediatricians must carefully navigate these ethical decisions, ensuring that the child’s well-being remains the central focus while considering the perspectives and wishes of the family. It is essential to involve an ethics committee or seek counsel when there is significant uncertainty or disagreement regarding the best course of action. Pediatricians should strive to ensure that the decisions made are in the child’s best interests, taking into account both medical evidence and the family's values.

Track 16: Pediatric Pulmonology

Pediatric pulmonology focuses on the diagnosis and treatment of respiratory diseases in children, including asthma, cystic fibrosis, and bronchopulmonary dysplasia. Advances in pediatric pulmonology have significantly improved the management of chronic respiratory conditions. New inhaler technologies, such as breath-actuated devices and nebulizers, have improved medication delivery and compliance. For conditions like cystic fibrosis, gene therapy and targeted treatments are providing more effective management options, prolonging life expectancy. Advances in the understanding of the genetic and environmental factors contributing to asthma have led to more personalized treatment plans, improving asthma control and reducing exacerbations. Improved diagnostic techniques, such as high-resolution imaging and bronchoscopy, have also enhanced the early detection of lung diseases, facilitating timely interventions and reducing the risk of long-term complications.

Track 17: Vaccination Trends and Challenges

Vaccination remains one of the most effective public health measures for preventing infectious diseases in children. However, despite widespread immunization efforts, there are ongoing challenges related to vaccine hesitancy, access, and equity. Vaccination trends show a strong emphasis on developing new vaccines to prevent emerging diseases such as respiratory syncytial virus, while existing vaccines continue to undergo improvements to increase efficacy and safety. Challenges include misinformation, cultural factors, and logistical issues in vaccine distribution, particularly in low-income and rural areas. The rise of vaccine hesitancy, fueled by misinformation, has contributed to outbreaks of preventable diseases like measles in certain regions. Public health campaigns, educational initiatives, and improved vaccine delivery systems are essential to overcoming these challenges and ensuring that all children receive the benefits of vaccination.

Track 18: Sports Medicine for Young Athletes

Sports medicine for young athletes has evolved to focus not only on injury prevention but also on optimizing performance and addressing the physical and psychological needs of young athletes. Specialized pediatric sports medicine has become increasingly important as youth participation in competitive sports has risen. Advances in injury prevention, including the development of tailored training programs, proper equipment, and techniques, help reduce the risk of common injuries such as ACL tears, concussions, and stress fractures. Additionally, a growing understanding of the unique physical characteristics of children and adolescents has led to more age-appropriate training regimens and recovery strategies that prioritize long-term health. pediatric sports medicine has made significant strides in improving the safety and longevity of young athletes’ careers. By focusing on prevention, early intervention, and mental health support, healthcare providers are helping young athletes to achieve their best performance while safeguarding their long-term health.

Track 19: Advances in Pediatric Pharmacology

Advances in pediatric pharmacology have significantly improved the safety and effectiveness of medications for children. Pediatric pharmacology is evolving with a focus on individualized treatment, as children’s responses to medications can differ greatly from adults due to differences in metabolism, organ function, and developmental stages. Precision medicine, informed by genetic and biomarker information, is becoming more prevalent in guiding drug selection and dosage for children with complex conditions. This shift towards personalized treatment plans allows for better-targeted therapies, minimizing side effects and improving efficacy. For example, pharmacogenomics is increasingly used to identify genetic variations that may affect a child’s response to specific medications, allowing clinicians to choose drugs that are more likely to be effective and safe. These developments are leading to more effective and safer treatments for children, allowing for improved management of both common and complex health conditions.

Track 20: Collaboration in Pediatric Research

Collaboration in pediatric research has become increasingly important in addressing complex pediatric health issues. Interdisciplinary collaboration between pediatricians, researchers, specialists, and families leads to a more comprehensive understanding of pediatric diseases and treatment options. Recent advancements in technology, such as genomics, have enabled a more integrated approach to research, allowing for the identification of new biomarkers and treatment targets for conditions like pediatric cancer and rare genetic disorders. By combining the expertise of various fields, research initiatives can more effectively tackle the challenges facing pediatric health. Global collaboration has facilitated the sharing of data and best practices, accelerating progress in pediatric research. Increased funding and support for collaborative efforts have enabled researchers to address health disparities in pediatric care. Engaging families as active partners in research not only enhances the relevance of studies but also ensures that outcomes are aligned with patient needs.

Market Analysis

The global Pediatric healthcare market is expected to grow from $11.81 billion in 2021 to $16.92 billion by 2029, representing a compound annual growth rate (CAGR) of 4.6%. This growth is largely attributed to the rising prevalence of chronic diseases among children, such as asthma, diabetes, obesity, and congenital heart defects. The pediatric vaccine market is projected to exceed $40 billion by 2022, with an estimated 500 million newborns expected to be vaccinated globally. Additionally, pediatric cardiology, pediatric oncology, and pediatric surgical markets are expanding as more cases of heart diseases and childhood cancers are being diagnosed. The pediatric cardiology market in the U.S. alone was valued at approximately $3.5 billion in 2015 and is expected to see steady growth due to an increase in pediatric heart disease cases. Similarly, the global pediatric oncology market, valued at $2.5 billion in 2020, is projected to grow at a CAGR of 5.2% by 2027.

Regionally, North America remains the largest market for pediatric healthcare, with the U.S. accounting for the bulk of the market share. In 2020, the pediatric healthcare market in North America was valued at approximately $6.8 billion, with the U.S. pediatric healthcare sector expected to reach $8.1 billion by 2025. Europe follows closely, with the pediatric healthcare market estimated at $4.3 billion in 2020 and expected to grow at a CAGR of 4.1% by 2025. Meanwhile, the Asia-Pacific region is expected to witness the fastest growth, with the market projected to grow from $3.6 billion in 2020 to $6.4 billion by 2027, driven by increased healthcare access in countries like China and India. The Middle East and Africa pediatric healthcare market is expected to reach $64 billion by 2023, growing at a CAGR of 4.1%, up from $48 billion in 2016. This is a result of improved healthcare infrastructure and increasing investments in child health initiatives. As of 2023, the pediatric ultrasound market alone is projected to reach $420.71 million, reflecting a growing demand for diagnostic tools in the pediatric sector.

The global pediatric medical device market, valued at $9.7 billion in 2020, is projected to reach $15.3 billion by 2027, growing at a CAGR of 6.7%. This growth is driven by innovations in pediatric surgical instruments, imaging systems, and diagnostic tools, with areas like pediatric neurology and pediatric orthopedics witnessing considerable technological advancements. Moreover, telemedicine in pediatric care has been gaining traction, with the telehealth market for pediatric services projected to grow from $1.7 billion in 2020 to $6.4 billion by 2027, driven by the increasing demand for remote consultations and the integration of digital health platforms. The adoption of digital health technologies, including AI-powered diagnostics and remote patient monitoring, is expected to further improve healthcare delivery in pediatric care, particularly in underserved regions. These technological advancements, alongside continued policy support and greater access to care, will continue to propel the pediatric healthcare market forward in the coming years.

Pediatric Associations and Societies:

American Academy of Pediatrics
International Pediatric Association
Indian Academy of Pediatrics
European Pediatric Association
Canadian Pediatric Association
Academic Pediatric Association
The Asia-Pacific Pediatric Association
Indian Association of Pediatric Surgeons
American Pediatric Society/Society of Pediatric Research
American Pediatric Surgical Association
American Pediatric Surgical Nurses Association
American Society of Pediatric Hematology/Oncology
Society of Developmental and Behavioural Pediatrics
European Society for Pediatric Dermatology
Greater Atlanta Pediatric Society
Society for Academic Emergency Medicine
Advanced Pediatric Emergency Medicine Assembly
Aimee's Army Childhood Cancer Foundation
Alex's Lemonade Stand
Alliance for Childhood Cancer
American Brain Tumor Association
American Childhood Cancer Organization
Ashley Foundation
Pediatric Congenital Heart Association
Pediatrix Cardiology Associates of New Mexico
Society of Invasive Cardiovascular Professionals
Cardiovascular Credentialing International CCI

Participation Benefits

Participants will be honored with participation certificate

Specific speaker pages will be created in the website

Networking opportunities with global leaders

2 days complimentary breakfast, lunch and refreshments

Young researcher award and best poster award will be given to encourage young researchers

Submitted Abstracts will be published with High Impact Factor supporting journal with unique DOI number

Your clinic/organization name/logo will be published in our conference proceedings book and on our conference website

Past Conference Report

PEDIATRIC RESEARCH 2023

We take colossal delight to invite all the participants around the globe to join us at 10^th International Conference on Pediatrics Research and Adolescent Medicine taking place on June 12-13, 2023 at Vancouver, Canada. The Pediatric Research 2023 has turned in to a premier forum to network, learn and engage with professionals, academicians, scholars, researchers and activists in creating a platform to discuss and disseminate meaningful messages, values, and practices in the subject of Pediatric Research and Adolescent Medicine

Pediatrics field is growing rapidly, and its development is making tremendous impacts in Pediatric medicine and Medical Sciences. The significance and note worthiness can be measured by the way that it has made immense headways through the span of time and is proceeding to impact different parts of pediatric medicine.

Pediatrics Research conference will bring together pediatricians, general physicians, practitioners, researchers, clinicians in a universal forum, enabling the exchange of novel advancement in the field of Pediatrics & Primary Care in both science and practice. Pediatric Research-2023 is the best place to enhance networking and would provide opportunity to interact with world’s leading scientists and researchers.